The Best Yielding Healthcare Dividend Stocks With Fastest Earnings Growth

by Dividend Yield
+11.86%
Upside
30.39
Market
33.99
Trefis
PFE
Pfizer
Rate   |   votes   |   Share

This article was submitted by Dividend Yield using our Trefis Contributors tool

Growth is a wonderful instrument for wealth building. I screened the healthcare sector by stocks with the highest earnings per share growth for the next five years (at least 5 percent yearly). In addition, the company should pay today more than three percent in dividends. 10 stocks fulfilled my criteria of which six yielding above 4 percent. Nine stocks have a buy recommendation and one a strong buy rating.

Here are my favorite stocks:

1. GlaxoSmithKline (GSK)
has a market capitalization of $114.39 billion. The company employs 96,461 people, generates revenues of $44,734.36 million and has a net income of $2,919.58 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $8,615.36 million. Because of these figures, the EBITDA margin is 19.26 percent (operating margin 13.32 percent and the net profit margin finally 6.53 percent).

Twelve trailing months earnings per share reached a value of $2.05. Last fiscal year, the company paid $2.05 in form of dividends to shareholders.

Here are the price ratios of the company: The P/E ratio is 22.07, Price/Sales 2.50 and Price/Book ratio 8.10. Dividend Yield: 4.95 percent. The beta ratio is 0.61.

2. Johnson & Johnson (JNJ)
has a market capitalization of $179.39 billion. The company employs 117,000 people, generates revenues of $65,030.00 million and has a net income of $9,672.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $12,841.00 million. Because of these figures, the EBITDA margin is 19.75 percent (operating margin 19.01 percent and the net profit margin finally 14.87 percent).

Twelve trailing months earnings per share reached a value of $3.48. Last fiscal year, the company paid $2.25 in form of dividends to shareholders.

Here are the price ratios of the company: The P/E ratio is 18.86, Price/Sales 2.77 and Price/Book ratio is not calculable. Dividend Yield: 3.46 percent. The beta ratio is 0.55.

3. Abbott Laboratories (ABT) has a market capitalization of $84.53 billion. The company employs 90,000 people, generates revenues of $38,851.00 million and has a net income of $4,729.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $5,615.00 million. Because of these figures, the EBITDA margin is 14.45 percent (operating margin 14.45 percent and the net profit margin finally 12.17 percent).

Twelve trailing months earnings per share reached a value of $3.00. Last fiscal year, the company paid $1.92 in form of dividends to shareholders.

Here are the price ratios of the company: The P/E ratio is 18.06, Price/Sales 2.17 and Price/Book ratio is not calculable. Dividend Yield: 3.55 percent. The beta ratio is 0.29.

Take a closer look at the full table of best yielding healthcare growth stocks. The average price to earnings ratio (P/E ratio) amounts to 16.35. The dividend yield has a value of 3.71 percent. Price to book ratio is 2.77 and price to sales ratio 2.06. The operating margin amounts to 14.08 percent.

Related stock ticker symbols:

Rate   |   votes   |   Share

Comments

Name (Required)
Email (Required, but never displayed)
Be the first to comment!